Sennosides, USP 15 MG Chewable Tablet — RxCUI 251020
RxNorm drug concept · Semantic clinical drug
RxCUI 251020
Semantic clinical drug · SCD
● Current RxNorm concept 10 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI251020
Official nameSennosides, USP 15 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assennosides 15 MG Chewable Tablet
FDA products mapped10
Package NDCs mapped12
Reported Medicaid activity (SDUD)3,564 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Senna: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
- How long does it take for senna to work?
- Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
- Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
🕸️ Concept Web — How Sennosides, USP 15 MG Chewable Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sennosides, USP 15 MG Chewable Tablet
RxCUI 251020 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sennosides, USP
36387IN
-
Sennosides, USP
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ex-Lax Chocolated
217013BN
-
Ex-Lax Chocolated
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sennosides, USP Chewable Tablet
373857SCDF -
Sennosides, USP Chewable Product
1294747SCDG -
Sennosides, USP Oral Product
1159068SCDG -
Sennosides, USP Pill
1159069SCDG -
Sennosides, USP Chewable Tablet [Ex-Lax Chocolated]
369658SBDF -
Ex-Lax Chocolated Chewable Product
1296242SBDG -
Ex-Lax Chocolated Oral Product
1171828SBDG -
Ex-Lax Chocolated Pill
1171829SBDG - +4 more in this family
-
Sennosides, USP Chewable Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sennosides, USP 15 MG
331425SCDC -
Sennosides, USP 15 MG Chewable Tablet [Ex-Lax Chocolated]
213071SBD -
Sennosides, USP 15 MG [Ex-Lax Chocolated]
573006SBDC
-
Sennosides, USP 15 MG
Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sennosides, USP 15 MG
SCDC · 331425 -
Sennosides, USP Chewable Tablet
SCDF · 373857 -
Sennosides, USP Chewable Product
SCDG · 1294747 -
Sennosides, USP Oral Product
SCDG · 1159068 -
Sennosides, USP Pill
SCDG · 1159069
Brand-Name Concepts
-
Sennosides, USP 15 MG Chewable Tablet [Ex-Lax Chocolated]
SBD · 213071 -
Sennosides, USP 15 MG [Ex-Lax Chocolated]
SBDC · 573006 -
Sennosides, USP Chewable Tablet [Ex-Lax Chocolated]
SBDF · 369658 -
Ex-Lax Chocolated Chewable Product
SBDG · 1296242 -
Ex-Lax Chocolated Oral Product
SBDG · 1171828 -
Ex-Lax Chocolated Pill
SBDG · 1171829 -
Ex-Lax Chocolated
BN · 217013
📦 FDA Products & Package NDCs
10 products · 12 package NDCs
12 package NDCs map to RxCUI 251020 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00067-8140-01 | 1 PACKAGE in 1 BOX (0067-8140-01) / 12 TABLET, CHEWABLE in... | EX-LAX REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE | Haleon US Holdings LLC | 2017-08-01 |
| 00067-8140-02 | 2 PACKAGE in 1 BOX (0067-8140-02) / 12 TABLET, CHEWABLE in... | EX-LAX REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE | Haleon US Holdings LLC | 2017-08-01 |
| 00067-8140-03 | 4 PACKAGE in 1 BOX (0067-8140-03) / 12 TABLET, CHEWABLE in... | EX-LAX REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE | Haleon US Holdings LLC | 2017-08-01 |
| 00363-5000-24 | 2 POUCH in 1 CARTON (0363-5000-24) / 12 TABLET, CHEWABLE in... | Chocolated Laxative | Walgreens | 2014-04-10 |
| 36800-0994-01 | 2 POUCH in 1 CARTON (36800-994-01) / 12 TABLET, CHEWABLE in... | Chocolated Laxative Regular Strength Sennosides Stimulant Laxative TopCare health | Topco Associates | 2021-03-26 |
| 49035-0349-24 | 2 POUCH in 1 CARTON (49035-349-24) / 12 TABLET, CHEWABLE in... | Chocolate Laxative Regular strength, Sennosides Stimulant Laxative, equate | Wal-Mart Stores Inc | 2021-02-23 |
| 55910-0365-12 | 1 POUCH in 1 CARTON (55910-365-12) / 12 TABLET, CHEWABLE in... | Chocolated Laxative Regular Strength Sennosides Stimulant Laxative, DG health | Dolgencorp Inc. | 2021-02-23 |
| 63868-0266-24 | 2 POUCH in 1 CARTON (63868-266-24) / 12 TABLET, CHEWABLE in... | Chocolated Laxative | C.D.M.A., Inc. | 2014-01-01 |
| 63941-0980-24 | 2 POUCH in 1 CARTON (63941-980-24) / 12 TABLET, CHEWABLE in... | Chocolated Laxative Regular Strength Sennosides Stimulant Laxative, Best Choice | Valu Merchandisers Company | 2021-02-24 |
| 70000-0477-01 | 2 POUCH in 1 CARTON (70000-0477-1) / 12 TABLET in 1 POUCH | Leader Regular Strength Chocolate Laxative sennosides | CARDINAL HEALTH | 2019-01-01 |
| 79481-0860-01 | 24 TABLET, CHEWABLE in 1 CARTON (79481-0860-1) | Sennosides | Meijer, Inc. | 2023-09-15 |
| 83455-0300-24 | 24 TABLET, CHEWABLE in 1 CARTON (83455-300-24) | Equaline Regular Strength Chocolated Stimulant Laxative | United Natural Foods, Inc. dba UNFI | 2024-01-01 |
Observed labelers:
Haleon US Holdings LLC (3) ·
C.D.M.A., Inc. (1) ·
CARDINAL HEALTH (1) ·
Dolgencorp Inc. (1) ·
Meijer, Inc. (1) ·
Topco Associates (1)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.